help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reyes, J. L.
Right arrow Articles by Jaramillo-Juárez, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reyes, J. L.
Right arrow Articles by Jaramillo-Juárez, F.
Endocrinology Vol. 139, No. 4 1581-1587
Copyright © 1998 by The Endocrine Society


ARTICLES

Influence of Sex Differences on the Renal Secretion of Organic Anions

José L. Reyes, Estela Meléndez, Augusto Alegría1 and Fernando Jaramillo-Juárez

Department of Physiology (J.L.R., A.A.), Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, México, D.F. 07000; Department of Pharmacy (E.M.), Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, México, D.F. 11340; and Department of Pharmacology and Physiology (F.J.-J.), Centro Básico, Universidad Autónoma de Aguascalientes, Mexico, D.F. 20100

Address all correspondence and requests for reprints to: Jose L. Reyes, M.D., Ph.D., Department of Physiology and Biophysics, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, P.O. Box 14–740, México, D.F. 07000, Mexico. E-mail: jreyes{at}fisio.cinvestav.mx


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The kidney’s responsiveness to male sexual hormones has been often neglected. Renal secretion of organic anions is higher in male than in female individuals; as a consequence, most of the xenobiotics that are excreted from the organism through this pathway are eliminated more rapidly by males than by female animals. To gain further insight into this issue, we studied in vitro and in vivo characteristics of the transport of p-aminohippurate (PAH), a suitable marker for this system, in male and female rats, under different hormonal conditions. Kinetics of PAH showed a shorter elimination half-time in male than in female rats (t1/2el: male = 16.2 ± 2.1 min, female = 25.7 ± 4.5 min, P < 0.05). Castration of male rats increased t1/2el to a value similar to that of female rats (t1/2el: orchiectomized rat = 28.1 ± 7.1 min). Testosterone treatment of female rats increased the elimination rate to a value similar to that of male rats. In vitro PAH uptake by renal cortical slices from intact male rats was higher than that by slices from orchiectomized rats. Kinetic analyses of PAH uptake suggest that the difference was caused by a lower number of transporting molecules in orchiectomized than in intact animals, whereas the transporting capacity for each carrier was similar in male and in orchiectomized rats. Our results suggest that testosterone increases the number of functional carriers for PAH in the kidney.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
THE KIDNEY is a target organ for several hormones, with important physiological and pathological effects on the systemic and renal functions. Thyroid hormones have stimulatory effects on the function of renal cells, e.g. secretion (1). PTH, in addition to its role on calcium regulation, also shows some degree of stimulation of secretory mechanisms (2). In regard to sexual hormones, it has been suggested that testosterone has a stimulatory effect on several renal cellular functions, such as secretion (3), whereas female sexual hormones do not show any clear effect on secretion (4). The action of testosterone results in a higher maximal transport capacity for glucose and a faster renal blood flow in men than in women. Testosterone increased chloride transepithelial transport and cAMP levels in an established cell line (MDCK) derived from canine distal nephron (5). Differences between species have been noticed. O’Connell et al. (6) reported that male dogs have a higher secretion of creatinine than females; administration of testosterone to females made their secretory capacity equal to that of male dogs. Harvey and Malvin (7) reported that male rats secrete creatinine, probably through the organic anion pathway, but female rats do not. Important consequences for pharmacokinetics stem from these differences (males eliminate drugs faster than females), but they have seldom been taken into consideration. This is specially relevant to the use of drugs with a narrow therapeutic index and high potential toxicity. Because the kidney‘s sensitivity to some hormones and the hormonal metabolism itself vary along the life span, it is expected that the kinetics of xenobiotics will show significant differences related to the individual’s age (8) and gender. To analyze the kinetic behavior of the kidney’s major secretory pathway, the organic anion transporting mechanism, we performed in vivo and in vitro studies on the dynamics of p-aminohippurate (PAH), a suitable marker of this secretory pathway (9), on male and female adult rats, under different hormonal conditions.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animals
Sixty-day-old Wistar rats were used. At this age, sexual maturation has already been achieved (10). Animals were grown in our animal house and kept at 22–25 C temperature, and 50–55% humidity. They were fed standard Purina chow (Purina, Alief City, TX) and water ad libitum.

Pharmacokinetic studies
Rats were anesthetized with pentobarbital (30 mg/kg BW, ip). The trachea was isolated, and a catheter was inserted to allow adequate ventilation. The carotid artery and the jugular vein were both catheterized to obtain samples and to administrate test compounds, respectively. For the kinetic studies, 300-µl blood samples were obtained at 2, 5, 10, 15, 30, 60, 90, 120, and 150 min after administration of the test compound. A blood sample obtained at the beginning of the experiment was used as a blank and to determine the initial hematocrit count. A final sample for hematocrit was obtained, once the sampling for kinetics was completed. An equivalent volume of isotonic saline solution was infused to restore the amount extracted in the samples.

PAH has been extensively used as an indicator of the renal secretory pathway of organic anions, because it is not biotransformed and is secreted by the proximal tubule. This compound was chosen to estimate its disappearance rate from plasma in male and female rats and to look for differences possibly attributable to sexual dimorphism. A single bolus of PAH (10 mg/kg BW, aqueous solution, iv) was administered. This dose does not saturate the transport system (11); therefore, the kinetics can be adequately estimated.

The size of the experimental groups was determined with basis on the method for sample size estimation in infinite populations (12), and each group was formed by 20 rats. All experimental procedures were performed in accordance with international recommendations for the use and care of laboratory animals.

Measurement of PAH in plasma samples
Concentrations of PAH in plasma were measured using the method described by Bratton and Marshall (13), modified for small samples. Briefly, 300 µl trichloroacetic acid (10%) were added to 300 µl blood. The mixture was agitated and centrifuged for 3 min at 3500 rpm. A 400-µl aliquot of the protein-free filtrate was obtained, added with 50 µl trichloroacetic acid and 150 µl of HCl (1.2 N), agitated, and centrifuged at 3500 rpm for 3 min. The supernatant was separated, and 150 µl NaNO2 (0.1%) were added. Ammonium sulfamate (0.5%, 150 µl) was added, followed by the addition of 150 µl N-1-naphthylethylenediamine dihydrochloride (0.1%). Samples were kept in the dark for 20 min. Sample absorbance was measured at 540 nm in a spectrophotometer (Beckman DU50, Mexico City, Mexico). This modification to the method of Bratton and Marshall allowed the use of small-volume (300 µl) blood samples; the percent recovery was 94, with a detection limit of 0.1 mg/ml. We used plasma of the same animal as a blank to correct for the absorbance caused by plasma components other than PAH.

Effect of testosterone on the PAH kinetics in female rats
Renal cells are sensitive to the effect of testosterone. Among other effects, testosterone promotes protein synthesis in mice (14). The effect of exogenous testosterone was assessed in intact adult female rats. Testosterone (10 mg/kg BW, im, in sesame oil) was given to 20 rats (169.7 ± 11.6 g BW) for 7 days. This treatment was similar to that described by Köening et al. (15) to induce synthesis of renal enzymes in female mice. At the end of treatment, PAH kinetic studies were performed in these animals. PAH was administered as a single bolus (10 mg/kg BW, iv). Sampling was performed as previously described.

Acute effect of testosterone in male rats
Janne et al. (16) reported that testosterone induced protein synthesis in the mouse kidney, which was detectable 2 h after administration. Similarly, creatinine clearance increased 150–330 min after intramuscular administration of testosterone to rats (17). To study the acute effect of testosterone on PAH kinetics in the male rat, the hormone was administered to 20 rats in a single dose (20 mg/kg BW, im) 170 min before the PAH kinetic studies described above. This dose is 20-fold higher than the dose required to induce an androgen effect in rats (18).

Effect of orchiectomy on PAH kinetics in rats
To induce an acute reduction of the androgen effect, 20 45-day-old rats were subjected to orchiectomy 15 days before the PAH kinetic studies. This period was chosen because 10 days after castration, the serum concentration of testosterone declines by 90% (19). The experimental procedure followed in the kinetic analysis was the same as described above.

Effect of acute administration of testosterone on the kinetics of PAH in orchiectomized rats
To study the effect of a substitutive androgen therapy in orchiectomized rats, testosterone (20 mg/kg BW, im) was administered to 20 rats on day 15 after surgery. PAH kinetic studies were performed 170 min after administration. The testosterone dose used in this experimental series is higher than that employed by Fedor et al. (20) for substitutive therapy in orchiectomized rats.

Effect of castration on the renal tubular secretion of PAH in female rats
Some metabolic effects of testosterone may be mediated by the interaction of the hormone with estrogen receptors in the target cells. We considered it of interest to study whether ovariectomy might affect PAH kinetics. Female adult Wistar rats were ovariectomized, and kinetic studies were performed in these animals.

Kinetic model for the elimination of PAH
Kinetic analysis was done considering a model of two open compartments, because the data (fitted by an automated least-squares procedure) were in agreement with this model (21), which is similar to those for indomethacin (22) and arginine vasopressin in rats (23). Concentration decreases in the central compartment after a biexponential function, represented by the equation:

Constants {alpha} and ß represent the disappearance rates for the distribution and elimination components, respectively, and their values are given by the slopes of each of the adjusted curves. A and B represent the initial values of the distribution and elimination components, respectively, extrapolated from the y-axis intercept.

The biological half-time was calculated from:

The pharmacokinetic parameters were adjusted per 100 g of BW, because secretor function is dependent on body mass (24).

Time-course of PAH uptake by renal cortical slices from orchiectomized or intact male rats
To prevent hemodynamic systemic factors from participating in the presumable differences between orchiectomized and intact male rats, we measured PAH uptake in cortical renal slices. Orchiectomized rats were used 15 days after surgery. Cortical slices were obtained from intact male or orchiectomized rats. The slices were incubated for 5, 10, 20, 40, 60, 90, and 120 min in Ringer solution containing 14C-PAH (10-6 M; SA, 41.3 mCi/mmol; New England Nuclear, Mexico City, Mexico), under gentle stirring, at 25 C, and gassed with 95% O2-5% CO2. At the end of each period, one group of slices was retired from the incubation media and blotted. Slices were dried overnight at 80 C. Dry weight of tissue pieces was recorded in a Mettler (Mexico City, Mexico) M-5 balance, and results are expressed as dpm per mg dry weight. Samples were digested with a commercial solubilizer (NCS, Amersham Co., Mexico City, Mexico) at 50 C for 60 min in separate vials, and 10 ml scintillation liquid (Instagel, Packard, Mexico City, Mexico) were added after cooling the digested material. Radioactivity was measured in a liquid scintillation counter (Packard Tri Carb, mod 3255, Instrumental Technion, Mexico City, Mexico), and corrections for quenching and background were made. Nonspecific uptake was determined in another group of slices incubated in the presence of radioactive PAH (10-6 M) and probenecid (10-4 M, Sigma Chemical Co., St. Louis, MO), as previously described (25).

Binding of PAH to plasma proteins
Pharmacokinetics is highly dependent on the degree of drug binding to plasma proteins. Therefore, we decided to study whether the binding of PAH to these proteins might explain the differences observed between male and female rats in renal excretion of PAH.

Sixty-day-old male and female rats were anesthetized with ether. Blood was obtained by cardiac puncture, and 9 ml were mixed with 1 ml sodium citrate (3.8%). This mixture was centrifuged at 2000 rpm for 8 min. Aliquots of 1 ml of plasma were incubated in the presence of 14C-PAH (SA, 41.3 mCi/mmol; New England Nuclear) at 5, 10, and 20 mM, at 37 C, under constant stirring for 30 min. Then, duplicates of 100 µl were obtained, and the remaining 800 µl were put into dialysis bags. Plasma samples in the bags were introduced into vials containing 10 ml of phosphate buffer solution (pH 7.4), which were then incubated for 24 h, at 37 C, under gentle stirring. After incubation, duplicated aliquots (100 µl) were obtained from the bags contents and from the incubation media. These samples were mixed with 500 µl of a commercial solubilizer and 10 ml of scintillation solution (New England Nuclear). Radioactivity was measured in a liquid scintillation spectrophotometer (Tri-Carb, Packard). Corrections for background and quenching were made.

Renal clearance studies
Female and male Wistar rats, weighing 256 ± 8 and 306 ± 17 g BW, respectively, were anesthetized with pentobarbital (30 mg/kg, ip). The jugular vein, the femoral artery, and the trachea were catheterized with polyethylene tubing. The bladder was catheterized with a double polyethylene tube, allowing for air injection to expedite emptying. After the surgical preparation, plasma separated from blood collected from other rats was injected (1.4 ml/100 g BW) at a rate of 0.1 ml/min, to compensate for blood loss during surgery. Inulin and PAH prime and sustaining infusions were given via the jugular vein, and 3% mannitol in saline solution was infused at a rate of 0.1 ml/min during the experiments.

Inulin and PAH were measured as previously described (26).

Statistical analysis
The data were analyzed with one-way ANOVA by means of a commercial software. A value of P < 0.05 was considered as statistically significant. In addition, to study similarities among groups, we performed the Duncan’s multiple-ranks test. Values for elimination half-time (t1/2el) are expressed as mean ± SD. All other values are mean ± SEM


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The kinetics of PAH elimination was significantly faster in intact males than in female rats, whereas the distribution kinetics was similar in both groups (Fig. 1Go).



View larger version (17K):
[in this window]
[in a new window]
 
Figure 1. Time course of the disappearance of PAH from plasma. A single bolus of PAH (10 mg/kg BW, aqueous solution, iv) was administered to anesthetized, intact male ({triangleup}) or female ({blacksquare}) rats. Calculations were made from the equation: t1/2el = 0.693/ß. Values are mean ± SD. Means ± SEM are shown in the plotting, n = 20 for each group.

 
In female rats treated with testosterone, the t1/2el reached values similar to those of control male rats (Fig. 2Go), suggesting that the tubular handling of PAH is susceptible to being modulated by this hormone in the intact female rat.



View larger version (12K):
[in this window]
[in a new window]
 
Figure 2. Effect of testosterone on the PAH t1/2el. Kinetic studies of PAH disappearance were performed in anesthetized male (empty bar), female (filled bar), and testosterone-treated female rats (hatched bar), at a dose of 10 mg/kg BW, im, for 7 days. Means ± SD are shown, n = 20 for each group. **, P < 0.01.

 
To corroborate this finding, male rats were castrated, and 15 days after orchiectomy, PAH t1/2el increased significantly (Fig. 3Go), reaching values similar to those of female rats (castrated male: 28.1 ± 7.1, and female rat: 25.7 ± 4.5 min, respectively). These findings suggest that PAH secretion was dependent on testosterone activity.



View larger version (18K):
[in this window]
[in a new window]
 
Figure 3. Time course of the disappearance of PAH from plasma. A single bolus of PAH (10 mg/kg BW, aqueous solution, iv) was administered to anesthetized intact ({triangleup}) or orchiectomized ({blacktriangledown}) male rats. Experiments in the castrated animals were performed 15 days after surgery. Means ± SEM are shown, n = 20 for each group. Values for t1/2el are mean ± SD.

 
To assess the dependence of this change on testosterone, we treated castrated male rats with this hormone, and we observed that the PAH t1/2el was similar to that of intact males (Fig. 4Go). Administration of testosterone to intact male rats did not change the PAH t1/2el (intact male: 16.2 ± 2.1 vs. testosterone-treated male: 18.6 ± 2.6 min). Our results show that substitutive treatment with testosterone offsets the increase in the PAH t1/2el produced by orchiectomy, in line with the suggestion that testosterone activity is critical for the maintenance of the functional sexual dimorphism in the kidney.



View larger version (13K):
[in this window]
[in a new window]
 
Figure 4. Restoration of the rate of PAH elimination from plasma with testosterone in orchiectomized rats. The disappearance of PAH from plasma was measured in intact (empty bar), orchiectomized (filled bar), and testosterone-treated orchiectomized male rats (hatched bar). Rats from this last group were treated with a single dose (20 mg/kg BW, im) of hormone, 170 min before the kinetic studies were performed. Means ± SD are shown, n = 20 for each group. **, P < 0.01.

 
In contrast to the stimulatory effect of testosterone, ovariectomy had no effect on the PAH t1/2el (intact female: 25.7 ± 4.5 and ovariectomized rat: 23.3 ± 3.7 min).

Duncan’s multiple ranks test showed that the experimental series can be fitted into two groups: the first group formed by intact males, testosterone-treated females, orchiectomized males treated with testosterone, and intact males also treated with testosterone. All these experimental conditions depicted an accelerated t1/2el for PAH, and among these groups there were no statistical differences. The second group would be formed by intact females, orchiectomized rats, and ovariectomized rats. The animals under these hormonal conditions depict slow t1/2els for PAH, which were statistically different from those of the first group (P < 0.01).

Effect of orchiectomy on the PAH uptake by cortical slices
To examine the tubular component of PAH excretion, in the absence of confounding factors such as renal hemodynamics and hepatic metabolism or excretion of this compound, we studied the in vitro uptake of PAH by cortical slices obtained from orchiectomized or intact male rats. Uptake was significantly higher in slices from intact male rats than in those from orchiectomized rats (Fig. 5Go). Kinetic analysis of the initial uptake rate showed that this parameter was similar in slices from intact males and in those from orchiectomized rats, k = 0.066 min-1 and k = 0.059 min-1, respectively (Fig. 5Go, insert). These results suggest that the differences between intact males and orchiectomized rats are caused by a greater number of transporting sites for PAH in the intact animals than in the orchiectomized ones. However, the analyses of the initial uptake rates indicate that these transporting sites have the same affinity in both groups of animals. Therefore, the main effect of testosterone is to modulate the number of functional transporting molecules in the cell membrane, without producing any evident changes in the transport speed of each of these carriers.



View larger version (26K):
[in this window]
[in a new window]
 
Figure 5. PAH uptake by renal cortical slices obtained from intact and orchiectomized male rats. Renal cortical slices were incubated in Ringer solution containing 14C-PAH (1 µM; SA, 41.3 mCi/mmol), for 5, 10, 20, 40, 60, 90, and 120 min. At the end of each period, one group of slices was retired from the incubation media and blotted. Radioactivity was measured in those samples and expressed as cpm/mg dry weight. Means ± SEM are shown. *, P < 0.05.

 
Renal clearances of inulin and PAH
There were no differences in inulin or PAH clearances between male and female rats (Fig. 6Go). These results indicate that renal hemodynamics does not contribute to the differences observed in PAH kinetics between intact male and female rats.



View larger version (20K):
[in this window]
[in a new window]
 
Figure 6. Renal hemodynamics in intact male and female rats. Clearance of PAH and inulin were measured to estimate renal plasma flow and glomerular filtration rate, respectively, in anesthetized intact male (empty bars) and female rats (filled bars). Means ± SEM are shown, n = 10.

 
Binding of PAH to plasma proteins
The degree of PAH binding to plasma proteins might be a significant factor contributing to the differences observed in its kinetic behavior in male and female rats. It was mandatory, therefore, to study this issue. We found that binding of PAH to plasma proteins was similar in male and female rats (Table 1Go), which indicates that protein binding does not contribute to the more rapid elimination of PAH by male rats.


View this table:
[in this window]
[in a new window]
 
Table 1. Binding of PAH to plasma proteins

 
Weight and hematocrit in male and female rats
Animals from comparable experimental groups had similar body weights. As expected, male rats were heavier than female rats of similar age (Table 2Go). The final hematocrit counts were lower than initial values, and this change was similar in all the series. There was an average decrease of 6.9 ± 0.2% for all the groups. There was no apparent relationship between the observed differences in the kinetics of PAH and the degree of change in the hematocrit count (Table 2Go).


View this table:
[in this window]
[in a new window]
 
Table 2. Weight and initial and final hematocrit in wistar rats under different experimental conditions

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The kidney’s role as a target organ for androgens is frequently neglected. The main finding of this study was the participation of testosterone in the regulation of the renal capacity to secrete PAH. This compound has been widely used as an indicator of the organic anion secretory pathway, which is the major route for elimination of xenobiotics from the body. Therefore, changes in the excretory ability of this system to dispose of these compounds are of clinical relevance, particularly to the use of drugs with high toxicity and narrow therapeutic index, such as those used in the therapy of malignant processes. The need for a careful monitoring of drug concentrations in the blood of patients receiving these therapies has also been recognized. The importance of monitoring becomes evident in those cases in which androgen antagonizing drugs are used simultaneously with potentially hazardous compounds, because a delay in the elimination of these drugs is to be expected. This would also be the case for the orchiectomized human male. On the contrary, if androgen therapy is administered, the elimination of other drugs given simultaneously will be accelerated, and the therapeutic effects might be reduced because of a shorter t1/2el.

We observed a shorter t1/2el in intact male rats than in orchiectomized or female rats. This effect of orchiectomy was offset by testosterone administration at doses intended to compensate for the decrement of the hormone induced by castration (20). These results provide evidence for a stimulatory effect of this hormone on the renal excretory function. Administration of testosterone to intact male rats did not significantly increase the elimination rate of PAH. Because the administration of testosterone followed a schedule similar to that used with female and castrated male rats, in which a clear reduction in the PAH t1/2el was observed, we can be confident that this lack of significant stimulation was not caused by a short time of observation for the hormone’s action or to a low dose; and this suggests that, under physiological conditions, testosterone concentrations in males’ plasma are adequate to exert its modulatory action on this renal secretory pathway.

We studied the effects of testosterone on other kidney functions, such as the glomerular filtration rate, measured in terms of inulin clearance. This parameter was similar in male and female rats, suggesting that the effects of testosterone on the renal capabilities show some selectivity and are not influenced to the same extent. We did not observe differences in PAH clearance between male or female rats. It must be emphasized that PAH and inulin renal clearance are indicators of renal hemodynamics (PAH clearance for renal plasma flow and inulin clearance for glomerular filtration rate). Therefore, our results suggest that testosterone does not play a major role in renal hemodynamics in the intact male or female rat.

Kleinman et al. (3) reported that PAH transport was higher in unanesthetized male rats than in female rats. We did not observe this sort of difference in PAH clearances, possibly because of a disparity in experimental approach; Kleinman et al. (3) studied PAH transport under maximum capacity conditions using PAH doses higher than those used by us. These observations stress the convenience of performing complete kinetic studies to disclose sex differences in the kidney function. Furthermore, in addition to the selectivity of the stimulatory effect of testosterone on renal secretion, but not on glomerular filtration rate or plasma renal flow, there also are differences that depend on the target organ. For instance, liver, submaxillary glands, and kidney are all androgen-responsive nonsexual organs. However, in the study reported by Paigen and Peterson (27), ß-glucoronidase activity in mice was induced in the kidney but not in the liver or in the submaxillary glands. This induction was age-dependent. In 10-day-old mice, there was no effect of testosterone, but there was an 8-fold increase in the activity of this enzyme in 30-day-old mice. Similar results were obtained with dihydrotestosterone.

An additional explanation might be put forward for the lack of gender differences in PAH clearance. The liver has an active transporting system for PAH, which is similar in its cell mechanisms to that of the kidney. Therefore, because we used a relatively low amount of PAH in the clearance studies, part of this material might have been captured by the liver, and this could have contributed to the lack of difference in renal clearances (28).

It should be emphasized that the distribution component of PAH kinetics did not differ in male, female, or castrated male rats. Therefore, the differences observed between male and female rats in PAH kinetics must be caused by the testosterone effects on the elimination component of the process, which is mostly dependent on the excretory capacity of the kidney. The degree of binding of some drugs to plasma proteins is an important factor that has to be taken into consideration when kinetic studies are performed (29, 30). Nevertheless, the differences in PAH kinetics observed between male and female rats in our study cannot be explained by the binding to plasma proteins, because this was similar in both groups.

In the in vivo studies, the higher capacity of male rats to eliminate PAH might be attributable to several factors, such as systemic or hepatic excretion of PAH through bile. Because we were interested in disclosing the effects of testosterone on epithelial cells, particularly those of the proximal tubule, we studied the effect of testosterone on renal cortical slices. Renal slices possess the secretory mechanism to transport PAH, and under these conditions, this mechanism can be studied in the absence of hemodynamic or other systemic factors. The measurements of in vitro PAH uptake by cortical slices showed that slices from orchiectomized rats had a lower ability to concentrate PAH than those from intact male rats. This finding suggests that testosterone has a positive effect on the modulation of the functional state of PAH-carrying molecules. Because the initial rates of PAH uptake were similar in slices from intact males and orchiectomized rats, we suggest that the hormone does not modify the affinity of the transporting molecules and that the main effect of testosterone is to increase the number of functional transporting molecules in the cell membrane. Further studies are required to fully clarify this issue.

Other renal effects of testosterone involve mechanisms that are important in the development of toxicity in this organ. Administration of hexachlorobutadiene, a nephrotoxic drug, was shown to induce more damage to proximal tubules in male than in female rats (31). N-acetyltransferase activity in male mice showed a 2-fold increase in kidney by 30 days post natal, whereas the kidney activity of this enzyme remained unchanged in female mice. Castration reduced the activity of this enzyme in the male kidney to female levels, whereas testosterone replacement restored original activity. Because N-acetylation participates in the transformation of hydrazine drugs and arylamine carcinogens into cytotoxic and carcinogenic products, differences in the activity of N-acetyltransferase associated with testosterone might explain, at least in part, the higher susceptibility of male mice to 2-acetylaminofluorene mutagenicity and carcinogenicity (32). It should be emphasized that testosterone does not always produce a stimulatory effect on the kidney. Suzuki et al. (33) reported that this hormone decreased the activity of carbonic anhydrase in a dose-dependent manner. In the same study, the activity of the brush border Mg2+/HCO3--adenosine triphosphatase (another protein involved in cell transport mechanisms) did not change after testosterone administration.

Sciarra et al. (19) reported that castration reduced circulating levels of testosterone by approximately 90%. The decrease in renal secretory ability showed by castrated animals in our study is in agreement with the expected effect from a reduction in testosterone circulating levels. The recovery of a high excretory capacity in castrated animals that received restoration treatment with testosterone only 170 min before being tested provides evidence of the plasticity of the renal secretory mechanisms.

In female rats, treatment with testosterone increased their secretory capacity to levels similar to those of intact male rats, thus suggesting that this hormone is responsible for the sexual dimorphism observed in the renal function of the rat. It is remarkable that the increased secretory capacity was not related to a higher body mass, because rats treated with testosterone had a lower average weight than the control female rats.


    Footnotes
 
1 Deceased. Back

Received July 24, 1997.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Capasso G, De Santo NG, Kinne R 1987 Thyroid hormones and renal transport: cellular and biochemical aspects. Kidney Int 32:443–451[Medline]
  2. Sicca DA, Schoolwerth AC 1996 Renal handling of organic anions and cations and renal excretion of uric acid. In: Brenner BM (ed) The Kidney, Brenner & Rector’s. W B Saunders, Philadelphia, vol 1:607–626
  3. Kleinman LI, Loewenstein MS, Goldstein L 1966 Sex difference in the transport of p-aminohippurate by the rat kidney. Endocrinology 78:403–406[Free Full Text]
  4. Bräunlich H, Fleck CH, Bajanowsky T, Miosge W 1993 Postnatal development of sex differences in renal tubular transport of p-aminohippurate (PAH) in rats. Exp Toxicol Pathol 45:309–313[Medline]
  5. Sandhu S, Silbiger SR, Lei J, Neugarten J 1997 Effects of sex hormones on fluid and solute transport in Madin-Darby canine kidney cells. Kidney Int 51:1535–1539[Medline]
  6. O’Connell JMB, Reneo JA, Mudge GH 1962 Renal tubular secretion of creatinine in the dog. Am J Physiol 194:135–142
  7. Harvey AM, Malvin RL 1965 Comparison of creatinine and inulin clearances in male and female rats. Am J Physiol 209:849–852[Abstract/Free Full Text]
  8. Galinsky RE, Eshima D, Hansen L, Greene J, Dillehay D, Taylor Jr A 1990 Effect of advanced age on p-aminohippurate-induced inhibition of renal tubular secretion in male Fischer 344 rats. Mech Ageing Dev 56:209–222[CrossRef][Medline]
  9. Roch-Ramel F, Besseghir K, Mürer H 1992 Renal excretion and tubular transport of organic anions and cations. In: Windhager WE (ed) Handbook of Physiology. Section 8. Oxford University Press, New York, vol 2:2189–2262
  10. Baker FJD 1970 Reproduction and breeding. In: Baker HJ, Lindsey JR, Weisbroth SH (eds) The Laboratory Rat. Academic Press, London, vol 1:153–168
  11. Bräunlich H, Fleck CH, Bajanowsky T, Miosge W 1983 Dosisabhängiget und altersgang des renalen tubulären transportes von p-aminohippursäure (PAH) bei ratten nach injektion von einzeldosen. Pharmazie 38:483–485[Medline]
  12. Daniel WW 1974 Analysis of variance. In: Biostatistics: A Foundation for Analysis in the Health Sciences. John Wiley & Sons, New York, pp 179–223
  13. Bratton AC, Marshall Jr EK 1939 Determination of p-aminohippurate. J Biol Chem 128:537–542[Free Full Text]
  14. Koibuchi N, Matsuzaki S, Ma HT, Sakai M, Yamaokas S 1993 Induction of ornithine decarboxylase immunoreactivity in the male mouse kidney following testosterone treatment: an axial heterogeneity in the proximal tubule. J Endocrinol 136:85–89[Abstract/Free Full Text]
  15. Köening H, Goldstone A, Blume G, Lu CY 1980 Testosterone-mediated sexual dimorphism of mitochondria lysosomes in mouse kidney proximal tubules. Science 209:1023–1026[Abstract/Free Full Text]
  16. Janne O, Bullock LP, Bardin CW, Jacobs ST 1976 Early androgen action in kidney of normal and androgen-insensitive (tfm/y) mice. Biochim Biophys Acta 418:330–343[Medline]
  17. Harvey AM, Malvin RL 1966 The effect of androgenic hormones on creatinine secretion in the rat. J Physiol (Lond) 184:883–888[Abstract/Free Full Text]
  18. Rossoff IF 1974 Handbook of Veterinary Drugs. Springer-Verlag, New York
  19. Sciarra F, Sorcini G, Di-Silverio F, Gagliardi V 1973 Plasma testosterone and androstenedione after orchiectomy in prostatic adenocarcinoma. Clin Endocrinol (Oxf) 2:101–109[Medline]
  20. Fedor HH, Naftolin F, Ryan KJ 1975 Male and female sexual responses in male rats given estradiol benzoate and 5alpha-androstane-17ß-1,3-one propionate. Endocrinology 98:136–141
  21. Gibaldi M 1967 Biopharmaceutic and clinical pharmacokinetics. Lea and Febiger, ed. 2, Philadelphia
  22. Reyes JL, Alegria A, Meléndez E, Namorado MC 1984 Role of hormones on the renal handling of indomethacin. Experientia 40:649 (Abstract)
  23. Mendoza ME, Namorado MC, Reyes JL 1995 Participation of the kidney in the kinetics of arginine vasopressin in the water-loaded rat. Arch Med Res 26:41–46[Medline]
  24. Edwards NA 1975 Scaling of renal functions in mammals. Comp Biochem Physiol A 52:63–66[Medline]
  25. Hernández ME, Reyes JL, Gómez-Lojero C, Sayavedra MS, Meléndez E 1993 Inhibition of renal uptake of p-aminohippurate and tetraethylammonium by the antioxidant ethoxyquin in the rat. Food Chem Toxicol 31:363–367[CrossRef][Medline]
  26. Jaramillo-Juárez F, Mello-Aires M, Malnic G 1990 Urinary and proximal tubule acidification during reduction of renal blood flow in the rat. J Physiol (Lond) 421:475–483[Abstract/Free Full Text]
  27. Paigen K, Peterson J 1981 The developmental appearance of androgen receptor protein and androgen inducibility of the Gus gene complex in mouse kidney. Dev Genet 2:269–277
  28. Pratt WB 1990 The entry, distribution and elimination of drugs. In:. Pratt WB, Taylor P (eds) Principles of Drug Action. The Basis of Pharmacology. Churchill Livingstone, ed. 3, New York, pp 281–288
  29. Rowland M 1980 Plasma protein binding and therapeutic drug monitoring. In: Tognoni G, Latini R, Jusko WJ (eds) Frontiers in Therapeutics Drug Monitoring. Raven Press, New York, pp 27–35
  30. Vorum H, Gram L, Honore B 1993 Valproate and palmitate binding to serum albumin in valproate-treated patients. Relations to obesity. Epilepsy Res 16:55–64[CrossRef][Medline]
  31. Birner G, Werner M, Ott MM, Dekant W 1995 Sex differences in hexachlorobutadiene-biotransformation and nephrotoxicity. Toxicol Appl Pharmacol 132:203–212[CrossRef][Medline]
  32. Smolen TN, Brewer JA, Weber WW 1993 Testosterone modulation of N-acetylation in mouse kidney. J Pharmacol Exp Ther 264:854–858[Abstract/Free Full Text]
  33. Suzuki S, Yoshida J, Takahashi T 1996 Effect of testosterone on carbonic anhydrase and Mg2+-dependent HCO3--stimulated ATPase activities in rat kidney: comparison with estradiol effect. Comp Biochem Physiol [C] 114:105–112



This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
R. Schneider, C. Sauvant, B. Betz, M. Otremba, D. Fischer, H. Holzinger, C. Wanner, J. Galle, and M. Gekle
Downregulation of organic anion transporters OAT1 and OAT3 correlates with impaired secretion of para-aminohippurate after ischemic acute renal failure in rats
Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1599 - F1605.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Ljubojevic, D. Balen, D. Breljak, M. Kusan, N. Anzai, A. Bahn, G. Burckhardt, and I. Sabolic
Renal expression of organic anion transporter OAT2 in rats and mice is regulated by sex hormones
Am J Physiol Renal Physiol, January 1, 2007; 292(1): F361 - F372.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. E. Groves, W. B. Suhre, N. J. Cherrington, and S. H. Wright
Sex Differences in the mRNA, Protein, and Functional Expression of Organic Anion Transporter (Oat) 1, Oat3, and Organic Cation Transporter (Oct) 2 in Rabbit Renal Proximal Tubules
J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 743 - 752.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
R. Ogawa, R. Kishi, K. Mihara, H. Takahashi, A. Takagi, N. Matsumoto, K. Masuhara, K. Nakazawa, F. Miyake, S. Kobayashi, et al.
Population Pharmacokinetic and Pharmacodynamic Analysis of a Class IC Antiarrhythmic, Pilsicainide, in Patients With Cardiac Arrhythmias
J. Clin. Pharmacol., January 1, 2006; 46(1): 59 - 68.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
C. Sauvant, H. Holzinger, and M. Gekle
Prostaglandin E2 Inhibits Its Own Renal Transport by Downregulation of Organic Anion Transporters rOAT1 and rOAT3
J. Am. Soc. Nephrol., January 1, 2006; 17(1): 46 - 53.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Ljubojevic, C. M. Herak-Kramberger, Y. Hagos, A. Bahn, H. Endou, G. Burckhardt, and I. Sabolic
Rat renal cortical OAT1 and OAT3 exhibit gender differences determined by both androgen stimulation and estrogen inhibition
Am J Physiol Renal Physiol, July 1, 2004; 287(1): F124 - F138.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. C. N. Buist, N. J. Cherrington, S. Choudhuri, D. P. Hartley, and C. D. Klaassen
Gender-Specific and Developmental Influences on the Expression of Rat Organic Anion Transporters
J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 145 - 151.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reyes, J. L.
Right arrow Articles by Jaramillo-Juárez, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reyes, J. L.
Right arrow Articles by Jaramillo-Juárez, F.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals